Lilly gains preliminary injunction to halt Teva's Evista generic
This article was originally published in Scrip
Executive Summary
Judge Sarah Evans Barker with the US District Court for the Southern District of Indiana has issued a preliminary injunction to prevent the at-risk launch of a generic version of Lilly's Evista (raloxifene) by Teva Pharmaceutical Industries until after the court makes its final ruling in an ongoing patent case.